179 related articles for article (PubMed ID: 37865978)
21. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
22. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
[No Abstract] [Full Text] [Related]
23. The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Bidet A; Troadec MB; Veronese L; Auger N; Daudignon A; Nadal N; Penther D; Michaux L; Lafage-Pochitaloff M; Lefebvre C
Leukemia; 2023 Apr; 37(4):946-947. PubMed ID: 36707618
[No Abstract] [Full Text] [Related]
24. Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
Lefebvre C; Veronese L; Nadal N; Gaillard JB; Penther D; Daudignon A; Chauzeix J; Nguyen-Khac F; Chapiro E
Curr Res Transl Med; 2023; 71(4):103425. PubMed ID: 38016420
[TBL] [Abstract][Full Text] [Related]
25. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Eclache V; Lafage-Pochitaloff M; Lefebvre C; Penther D; Raynaud S; Tigaud I
Ann Biol Clin (Paris); 2016 Oct; 74(5):525-534. PubMed ID: 27546835
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
28. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
29. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
30. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
Leukemia; 2020 Aug; 34(8):2262-2264. PubMed ID: 32042082
[No Abstract] [Full Text] [Related]
31. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F; Bidet A; Veronese L; Daudignon A; Penther D; Troadec MB; Lefebvre C; Lafage-Pochitaloff M
Leukemia; 2020 Jun; 34(6):1711-1713. PubMed ID: 31862958
[No Abstract] [Full Text] [Related]
33. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Dastugue N; Lafage-Pochitaloff M; Pagès MP; Radford I; Bastard C; Talmant P; Mozziconacci MJ; Léonard C; Bilhou-Nabéra C; Cabrol C; Capodano AM; Cornillet-Lefebvre P; Lessard M; Mugneret F; Pérot C; Taviaux S; Fenneteaux O; Duchayne E; Berger R;
Blood; 2002 Jul; 100(2):618-26. PubMed ID: 12091356
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nadal N; Auger N; Bidet A; Nguyen-Khac F
Curr Res Transl Med; 2023; 71(4):103426. PubMed ID: 38016423
[TBL] [Abstract][Full Text] [Related]
35. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
36. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.
Liu YC; Geyer JT
Pathobiology; 2024; 91(1):30-44. PubMed ID: 37311434
[TBL] [Abstract][Full Text] [Related]
37. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Schlegelberger B; Mecucci C; Wlodarski M
Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
[TBL] [Abstract][Full Text] [Related]
38. Unraveling germline predisposition in hematological neoplasms: Navigating complexity in the genomic era.
Jerez J; Santiago M
Blood Rev; 2024 Mar; 64():101143. PubMed ID: 37989620
[TBL] [Abstract][Full Text] [Related]
39. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
40. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]